Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

951 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: 5-Year Efficacy and Toxicity in the DELINEATE Trial.
Tree AC, Satchwell L, Alexander E, Blasiak-Wal I, deSouza NM, Gao A, Greenlay E, McNair H, Parker C, Talbot J, Dearnaley D, Murray J. Tree AC, et al. Among authors: talbot j. Int J Radiat Oncol Biol Phys. 2023 Feb 1;115(2):305-316. doi: 10.1016/j.ijrobp.2022.09.058. Epub 2022 Sep 21. Int J Radiat Oncol Biol Phys. 2023. PMID: 36150450 Clinical Trial.
A Randomised Phase II Trial to Evaluate the Feasibility of Radiotherapy Dose Escalation, Facilitated by Intensity-Modulated Arc Radiotherapy Techniques, in High-Risk Neuroblastoma.
Gains JE, Patel A, Chang YC, Mandeville HC, Smyth G, Stacey C, Talbot J, Wheatley K, Gaze MN. Gains JE, et al. Among authors: talbot j. Clin Oncol (R Coll Radiol). 2024 Jun;36(6):e154-e162. doi: 10.1016/j.clon.2024.03.004. Epub 2024 Mar 15. Clin Oncol (R Coll Radiol). 2024. PMID: 38553363 Free article. Clinical Trial.
Determining the incidence of interstitial pneumonitis and chronic kidney disease following full intensity haemopoetic stem cell transplant conditioned using a forward-planned intensity modulated total body irradiation technique.
Durie E, Nicholson E, Anthias C, Dunne EM, Potter M, Ethell M, Messiou C, Brennan J, Eagle S, Talbot J, Smyth G, Ingram W, Saran F, Mandeville HC. Durie E, et al. Among authors: talbot j. Radiother Oncol. 2021 May;158:97-103. doi: 10.1016/j.radonc.2021.02.020. Epub 2021 Feb 23. Radiother Oncol. 2021. PMID: 33636231
Management of the vertebrae as an organ at risk in paediatric radiotherapy clinical trials: Initial QUARTET experience.
Turcas A, Kelly SM, Bernier-Chastagner V, Bolle S, Cameron A, Corning C, Clementel E, Dieckmann K, Davila Fajardo R, Gaze MN, Laprie A, Magelssen H, Meroni S, Pignoli E, Safwat A, Scarzello G, Talbot J, Timmermann B, Boterberg T, Mandeville HC. Turcas A, et al. Among authors: talbot j. Radiother Oncol. 2023 Oct;187:109810. doi: 10.1016/j.radonc.2023.109810. Epub 2023 Jul 17. Radiother Oncol. 2023. PMID: 37468069 Free article.
Internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole: a pragmatic randomized controlled trial.
Lois N, Burr J, Norrie J, Vale L, Cook J, McDonald A, Boachie C, Ternent L, McPherson G; Full-thickness Macular Hole and Internal Limiting Membrane Peeling Study (FILMS) Group. Lois N, et al. Invest Ophthalmol Vis Sci. 2011 Mar 1;52(3):1586-92. doi: 10.1167/iovs.10-6287. Invest Ophthalmol Vis Sci. 2011. PMID: 21051731 Clinical Trial.
Mouth care in PICU.
Jiggins M, Talbot J. Jiggins M, et al. Among authors: talbot j. Paediatr Nurs. 1999 Dec-2000 Jan;11(10):23-6. Paediatr Nurs. 1999. PMID: 10723389 No abstract available.
Cancer-specific epigenome identifies oncogenic hijacking by nuclear factor I family proteins for medulloblastoma progression.
Shiraishi R, Cancila G, Kumegawa K, Torrejon J, Basili I, Bernardi F, Silva PBGD, Wang W, Chapman O, Yang L, Jami M, Nishitani K, Arai Y, Xiao Z, Yu H, Lo Re V, Marsaud V, Talbot J, Lombard B, Loew D, Jingu M, Okonechnikov K, Sone M, Motohashi N, Aoki Y, Pfister SM, Chavez L, Hoshino M, Maruyama R, Ayrault O, Kawauchi D. Shiraishi R, et al. Among authors: talbot j. Dev Cell. 2024 May 31:S1534-5807(24)00330-7. doi: 10.1016/j.devcel.2024.05.013. Online ahead of print. Dev Cell. 2024. PMID: 38834071
951 results